Health Condition 1: E119- Type 2 diabetes mellitus without complications
Conditions
Interventions
Intervention1: Katankateryadi Kwatha: Patients in Group A will be administered Trial Drug Katankateryadi Kwatha in the dose of 50 ml BD before meal for 30 days.
Intervention2: Indra Vati: Patients in
Sponsors
National Institute of Ayurveda Jaipur
Eligibility
Inclusion criteria
Inclusion criteria: i.Patient willing to sign the consent form. ii.Patients between the ages of 30-70 years of either sex. iii.Patients giving the clinical history of DM (Type II). iv.Patients having hyperglycemia confirmed by laboratory investigations i.e. Fasting Blood Sugar (FBS) >= 126mg/dl or Post Prandial Blood Sugar (PPBS) >= 200mg/dl or Glycosylated Hemoglobin (HbA1c) >= 6.5%. v.Presence of Cardinal symptoms of Diabetes Mellitus eg. (3P- polyuria, polydypsia, polyphagia).
Exclusion criteria
Exclusion criteria: i.Patients below 30years of age & above 70 years of age. ii.Patients having Type I DM. iii.Patients of Type II DM who are on insulin therapy. iv.Patients having any serious illness like Coronary Artery Disease, malignancy, etc. v.Drug induced DM. vi.F.B.S. > 200 mg/dl and P.P.B.S. > 300 mg/dl. vii.Patients having chronicity of more than 5 years. viii.DM with complications. ix.Pregnant and lactating mother.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Assessment of changes in specific signs and symptoms of Madhumeha and Type II Diabetes MellitusTimepoint: 30 days for Each Patients | — |
Secondary
| Measure | Time frame |
|---|---|
| Any adverse effect in the values of haematological test and in clinical signs and symptoms.Timepoint: 30 days for Each Patients | — |
Countries
India
Contacts
Public ContactDr Harish Bhakuni
National Institute of Ayurveda
Outcome results
None listed